Loading...

Faron Pharmaceuticals Oy

FPHAF•PNK
Healthcare
Biotechnology
$3.30
$0.00(0.00%)

Faron Pharmaceuticals Oy (FPHAF) Stock Overview

Explore Faron Pharmaceuticals Oy’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.7/100

Key Financials

Market Cap209.5M
P/E RatioN/A
EPS (TTM)$-0.44
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$1.46

FPHAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Faron Pharmaceuticals Oy (FPHAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 209.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.faron.com
358 2469 5151
Joukahaisenkatu 6 B, Turku, 20520

Company Facts

40 Employees
IPO DateApr 28, 2020
CountryFI

Frequently Asked Questions

;